CMC re-appoints R. Ramanan as MD CEO

1. Mr. Sudhir Vasudeva, Chairman & MD, Oil and Natural Gas Corporation, India (with Certificate in hand) 2. R Ramanan, MD & CEO CMC Limited 3. H.E. Hon. Sayyad ABD-AL-Cader SAYED-HOSSEN, Minister of Industry, Commerce and Consumer Protection, Govt.

KUALA LUMPUR: MIC strategic vice-chairman Datuk R. Ramanan said DAP secretary-general Lim Guan Eng had proven himself to be a bad leader. "DAP will sink because of Guan Eng's actions. He has betrayed party members," he said in a statement to the New ...

After a sleepless night, officials of the Hindustan Petroleum Corporation Limited (HPCL) heaved a sigh of relief on Friday for preventing any casualty and containing the fire to one of crude distillation units. "After taking stock of the fire ...

In my previous post I argued that, in passing H.R. 807 on May 9th, the House of Representatives might have unintentionally eliminated the debt ceiling as a serious political and operational consideration going forward. But upon further reflection, ...

Location: IPOH DAP vice-chairman M. Kulasegaran has hit back at his critics following comments that he did not do much to help the Indians. MIC strategic vice-chairman Datuk R. Ramanan recently said the Ipoh Barat MP had neglected the community. "He ...

(Targeted News Service Via Acquire Media NewsEdge) TORONTO, May 15 -- The University of Toronto issued the following news release: Five companies tackling pervasive healthcare challenges -- such as assessing dental health, helping patients and ...

QUIT COMPLAINING: PKR newsletter's apology has crushed allegations of BN bringing in phantom voters KUALA LUMPUR: OPPOSITION leader Datuk Seri Anwar Ibrahim has been told to quit harping on allegations of electoral fraud, considering PKR's own ...

Mobile devices pre-installed with Opera Seven Indian original-equipment manufacturers in the mobile phone and tablet space have inked a pact with Opera Software to pre-install the Opera Mini mobile web browser on the manufacturers' upcoming mobile ...

Staying up-to-date has never been simpler. Sign up for the today! EAST HANOVER, N.J., May 10, 2013 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab) for the treatment of ...